Universe Pharmaceuticals UPC
NASDAQ UPC
$3.94 +0.40 (+11.43%)
As of: Oct 21, 2026 · 11:20 AM EDT

Universe Pharmaceuticals (UPC) Current Deferred Revenue (2025 - 2026)

Updated

Universe Pharmaceuticals' Current Deferred Revenue was $42.01 billion in the quarter ended Mar 31, 2026.

Analysis

Universe Pharmaceuticals (UPC) Current Deferred Revenue (2025 - 2026) Analysis & Trends

As of Sep 30, 2025, Current Deferred Revenue at Universe Pharmaceuticals came in at $40.71 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Universe Pharmaceuticals 54.84 Mn -1.46 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 42,012.00
Sep 30, 2025 40,708.00
API Access

Universe Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=UPC&period=max&api_key=YOUR_API_KEY